AtriCure (NASDAQ: ATRC) revenue
AtriCure reported revenue of $534.5m for fiscal 2025, 14.9% more than in fiscal 2024 ($465.3m). Since fiscal 2016 its revenue has grown by 244.6%, an average growth of 14.7% a year.
AtriCure has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −10.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $534.5m | +14.9% | −$9.4m | −1.8% |
| 2024 | $465.3m | +16.5% | −$40.0m | −8.6% |
| 2023 | $399.2m | +20.8% | −$26.7m | −6.7% |
| 2022 | $330.4m | +20.4% | −$42.7m | −12.9% |
| 2021 | $274.3m | +32.8% | $55.2m | 20.1% |
| 2020 | $206.5m | −10.5% | −$44.2m | −21.4% |
| 2019 | $230.8m | +14.5% | −$33.1m | −14.4% |
| 2018 | $201.6m | +15.4% | −$17.1m | −8.5% |
| 2017 | $174.7m | +12.6% | −$25.0m | −14.3% |
| 2016 | $155.1m | — | −$31.1m | −20.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
AtriCure revenue compared with its sector
By revenue for its latest fiscal year, AtriCure ranks 188th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; AtriCure, 14.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 186th | Azenta | $593.8m | 3.6% |
| 187th | Bioventus | $568.1m | −0.9% |
| 188th | AtriCure | $534.5m | 14.9% |
| 189th | Mirum Pharmaceuticals | $521.3m | 54.7% |
| 190th | Veracyte | $517.1m | 16.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of AtriCure
- How much revenue did AtriCure make in fiscal 2025?
- AtriCure reported revenue of $534.5m for fiscal 2025, compared with $465.3m in fiscal 2024.
- How much has the revenue of AtriCure grown?
- Between fiscal 2016 and fiscal 2025 it went from $155.1m to $534.5m: 244.6% more, an average growth of 14.7% a year.
- What was the best year for revenue at AtriCure?
- Of its last 10 fiscal years, fiscal 2025, with $534.5m.
- Where does AtriCure rank in its sector by revenue?
- It ranks 188th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for AtriCure come from?
- From the annual report (Form 10-K) that AtriCure files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that AtriCure files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on AtriCure: the AtriCure page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.